Quarterly results round-up: Wright in line, Zoll's shares surge on strong Q3 performance
This article was originally published in Clinica
Executive Summary
US dental firm Dentsply International, which recently won the bidding race to acquire AstraZeneca's Astra Tech unit, has reported 8% revenue growth during its second fiscal quarter. The firm posted Q2 sales of $609.4m, compared with $565.1m during the same period last year. Its net income was also up, at $74.2m versus $72.4m in Q2 2010.